Mdma molecule:

Image from PubChem

Mdma Clinical Trials


Acute Effects of R- and S-MDMA in Healthy Subjects


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT05277636

Organisation Name: University Hospital, Basel, Switzerland

Overal Status: Not yet recruiting

Start Date: June 30, 2022

Last Update: March 31, 2022

Lead Sponsor: University Hospital, Basel, Switzerland

Brief Summary: Racemic ±3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to others. These acute subjective effects of MDMA may be helpful to assist psychotherapy and MDMA is currently investigated in phase 3 trials as a possible treatment in post-traumatic stress disorder.

Conditions:
  • Healthy


Total execution time in seconds: 0.4066789150238